Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
In 1993, STERIS entered into a joint venture with Indianapolis-based Ecomed, Inc., a manufacturer of hazardous waste disposal equipment.
When the acquisition was announced in December 1995, the company's stock dropped 22 percent in a single day.
By 1995, the company's revenues were almost evenly split between capital equipment sales and recurring sales of consumables, such as chemicals and other accessories.
The acquisition, which was completed in May 1996, added some 300 items to STERIS' product line.
As anticipated, revenues rose sharply--up to $587.8 million for the fiscal year ending March 31, 1997, a 544 percent increase from the previous year's $91.2 million.
After a six-month lull, STERIS re-entered the acquisitions game in mid-1997.
In November 1998, the company announced that its shares would begin trading on the New York Stock Exchange.
At the beginning of 1999, the company had sold more than 16,000 System 1 units to more than 3,700 facilities.
STERIS acquired Albert Browne Ltd in September 2004.
In 2012, Steris acquired US Endoscopy for $270 million.
In October 2014, Steris executed a tax inversion from the United States to the United Kingdom, via an offer made to acquire UK-based Synergy Health for $1.9 billion.
The tax inversion was notable as it was the first US inversion post the new rules introduced by the Obama administration in 2014 to curb US corporations moving their "legal domicile" to reduce their exposure to US corporate taxation.
On June 24, 2015, Steris announced the acquisitions of General Econopak for $175 million and Black Diamond Video for $51 million.
In June 2021, Steris acquired Cantel Medical Corporation a provider of infection prevention products and services to endoscopy, dental and dialysis.
Rate how well Steris lives up to its initial vision.
Do you work at Steris?
Does Steris communicate its history to new hires?
Company Name | Founded Date | Revenue | Employee Size | Job Openings |
---|---|---|---|---|
Stryker | 1941 | $18.4B | 43,000 | 1,991 |
Boston Scientific | 1979 | $12.7B | 36,000 | 428 |
McKesson | 1833 | $276.7B | 80,000 | 398 |
Johnson & Johnson | 1886 | $94.9B | 134,500 | 2,021 |
Cardinal Health | 1971 | $205.0B | 48,000 | 4,521 |
Danaher | 1969 | $31.5B | 80,000 | 2,223 |
Hospira | 2004 | $4.5B | 19,000 | 38 |
Express Scripts Holding | 1986 | $100.1B | 26,600 | 8 |
Visteon | 2000 | $3.8B | 10,000 | 10 |
CooperVision | 1958 | $1.1B | 25 | 21 |
Zippia gives an in-depth look into the details of Steris, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Steris. The employee data is based on information from people who have self-reported their past or current employments at Steris. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Steris. The data presented on this page does not represent the view of Steris and its employees or that of Zippia.
Steris may also be known as or be related to STERIS Corporation, STERIS plc, Steris, Steris Corporation and Steris PLC.